Cardinal Capital Management
Source: SEC Form 13F · as of Mar 2026Cardinal Capital Management holds 17 biotech & pharma companies tracked by BioSniper, totaling $125.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$125.8M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 116,381 | $28.4M |
| LLYELI LILLY & Co | 26,792 | $24.6M |
| MRKMerck & Co., Inc. | 96,637 | $11.7M |
| IDXXIDEXX LABORATORIES INC /DE | 14,107 | $7.9M |
| NVSNovartis AG | 49,684 | $7.6M |
| UTHRUNITED THERAPEUTICS Corp | 12,133 | $7.2M |
| REGNREGENERON PHARMACEUTICALS, INC. | 8,436 | $6.5M |
| BMYBRISTOL MYERS SQUIBB CO | 104,507 | $6.3M |
| PAHCPHIBRO ANIMAL HEALTH CORP | 99,026 | $5.5M |
| SNYSanofi | 75,027 | $3.6M |
| PFEPFIZER INC | 123,684 | $3.5M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 62,170 | $3.5M |
| JAZZJazz Pharmaceuticals plc | 14,709 | $2.8M |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 11,031 | $1.9M |
| NVONovo Nordisk A/S | 46,693 | $1.8M |
| UTMDUtah Medical Products Inc. | 26,543 | $1.7M |
| HALOHALOZYME THERAPEUTICS, INC. | 20,549 | $1.3M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.